Image
The 2018 Pitt Hopkins Research Foundation Science Symposium will be held on Thursday, June 21, 2018 at the Radisson Blu Mall of America, Bloomington, MN.

8:30 am - 5:00 pm
Lunch will be provided.
Cocktail reception to follow, 5:30 pm - 7:30 pm, Radisson Blu Lakeside Grill.

 


Address: 

Image


Hotel accommodations can be made at the Raddison Blu. To receive the group rate, please book your hotel by May 30, 2018. Please use this LINK to book your room.

Parking:

Complimentary day parking (will get tickets).
$15 overnight parking


Accomodations and hotel details can be found here.

 
______________________________________________________________________________
 
 

Symposium Agenda
 

Thursday, June 21st, 2018

 

Conference site:      Radisson Blu Mall of America 2100 Killebrew Drive, Bloomington, MN 55425


8:30 - 9:00 a.m.        Breakfast at conference site

                                   

9:00 – 9:10 a.m.       Welcome, Audrey Davidow Lapidus, President, Pitt Hopkins Research Foundation

 

                                   

SESSION I


9:10 – 9:35 a.m.       Epigenetic Approaches to Improving Cognition in Pitt Hopkins Syndrome, Andrew Kennedy, PhD, Assistant Professor, Bates College

9:35 – 10:00 a.m.     The Investigation of TCF4 Expression Patterns and Gene Reinstatement Strategies, Ben Philpot, PhD, Professor, Associate Director, UNC Neuroscience Center, Department of Cell Biology & Physiology and Sally Kim, Graduate Student, UNC, Philpot Lab

10:00 – 10:25 a.m.    Muscarinic Acetylcholine Receptor 4 (M4) as a Novel Target for Pitt Hopkins Syndrome, Annah Moore, B.S., B.A., Vanderbilt University, Sweatt Lab

10:30 – 10:45 a.m.    Questions for Session 1 Talks

 

10:45 – 11:00 a.m.   Break, Coffee and refreshments available


 

SESSION II


11:00 – 11:25 a.m.   Regulation of TCF4 Activity and Characterization of its Target Genes in Neurons, Tõnis Timmusk, PhD, Department of Gene Technology, Tallinn University of Technology

11:25 - 11:50 p.m.   Evidence for Myelination Deficits in Pitt Hopkins Syndrome, Brady Maher, PhD, Lieber Institute for Brain Development, Johns Hopkins Medical Campus

                               

11:50 – 12:15 p.m.  Gene Therapy for Pitt Hopkins Syndrome, Steven Gray, PhD, Associate Professor, Director, UTSW Viral Vector Facility, University of Texas Southwestern Medical Center

 

12:20 – 12:35 p.m.  Questions for Session 2 Talks

 

12:35 – 1:30 p.m.    Lunch

 

 

SESSION III


1:30 – 1:55 p.m.      Protein Replacement Therapy for Pitt Hopkins Syndrome, Michelina Iacovino, PhD, Assistant Professor, Los Angeles Biomedical Research Institute

1:55 – 2:20 p.m.      In Silico Drug Repurposing in Pitt Hopkins Syndrome, Ian Roberts, PhD, Chief Technology Officer, Healx Ltd.

 

2:20 – 2:40 p.m.      Repurposing for Rare Diseases, Sean Ekins, PhD, PHRF Scientific Advisory Board Member, CEO, Collaborations Pharmaceuticals

 

2:40 – 2:55 p.m.       Questions for Session 3 Talks

 

2:55 – 3:15 p.m.       Break

 

 

SESSION IV


3:15 – 3:40 p.m.      Pharmacological Screening in an In Vivo Pitt Hopkins Model, Daniel Marenda, PhD, Associate Professor, Department of Biology, Drexel University

3:40 – 4:00 p.m.       Registry Update, Jessica Fletcher, Vice President, Pitt Hopkins Research Foundation

 

4:00 – 4:25p.m.        Dallas Clinic Update, Kimberly Goodspeed, MD, Pitt Hopkins Clinic, University of Texas Southwestern Medical Center

 

4:25 – 4:45 p.m.       Closing Remarks, Sofia Pauca, Princeton University, Class of 2021, Sabine Kastner Lab, Neuroscience Institute

                                               

Adjourn    

                                

5:30 – 7:30 p.m.       Evening Reception for researchers and board members,  Lakeside Grill, cocktail reception                  

Radisson Blu Mall of America, 2100 Killebrew Drive, Bloomington, MN 55425
 





Friday, June 22nd, 2018

 

Conference site:    Embassy Suites by Hilton Bloomington

                             2800 American Boulevard West, Bloomington, MN 55431

8:00 – 8:20 a.m.       Welcome, Audrey Davidow Lapidus, President, Pitt Hopkins Research Foundation

 

LAY TALKS & PARENT INFORMATION        

 

8:20 – 8:40 a.m.       In Silico Drug Repurposing in Pitt Hopkins Syndrome, Ian Roberts, PhD, Chief Technology Officer, Healx Ltd.

 

8:45 – 9:15 a.m.       Development of New Therapeutics for Neurodevelopmental Disorders at the Vanderbilt Center for Neuroscience Drug Discovery: Focus on PTHS, Colleen Niswender, PhD, and Annah Moore, Graduate Student, Vanderbilt University, Sweatt Lab

 

9:20 – 9:45 a.m.     Your Poop: A New Lens into Disease, Daniel McDonald, PhD, American Gut Project, Rob Knight Lab, UC San Diego

 

9:50 – 10:05 a.m.    Break

 

10:05 – 10:30 a.m. Gene Therapy in Pitt Hopkins Syndrome, Steven Gray, PhD, University of Texas Southwestern Medical Center

 

10:35 – 10:55 a.m.     Dallas Clinic Update, Sailaja Golla, MD and Kimberly Goodspeed, MD, Pitt Hopkins Clinic, University of Texas Southwestern Medical Center    

           

11:00 – 11:45 p.m.    Turning Science into Solutions for Rare CNS Disorders, Robert Ring, PhD, Autó's Consulting & Drexel University

 

11:45 – 12:45 p.m.      Lunch

 

Parent programing in the afternoon.

Image